Back to: products

Global Injectable Drugs Market 2020-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery

PrintEmail
Nov 2021 - 165 Pages - From $2,900
(Excel Data Sheet: $2,000)
Description

The report cover may be different from the image shown.

Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

Global injectable drugs market will reach $1,037.7 billion by 2030, growing by 9.8% annually over 2020-2030 driven by the increasing prevalence of chronic diseases, rising use of self-administered Injectable formulations, technological advancements in drug development, and growing approvals of new injectable drugs such as COVID-19 vaccines.
Highlighted with 82 tables and 86 figures, this 165-page report “Global Injectable Drugs Market 2020-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery (Pre-filled Syringe, Infusions, Others), Application (Oncology, Infectious Diseases, Autoimmune, Cardiovascular), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global injectable drugs market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global injectable drugs market in every aspect of the classification from perspectives of Molecule Type, Drug Class, Delivery, Application, Distribution Channel, and Region.

Based on Molecule Type, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Small Molecule
• Large Molecule

Based on Drug Class, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Monoclonal Antibodies (mAbs)
• Immunoglobulin
• Insulin
• Vaccines
• Cytokines
• Peptide Hormone
• Blood Factors
• Other Drug Classes

Based on Delivery, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Pre-filled Syringe
• Infusions
• Other Deliveries

Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Oncology
• Infectious Diseases
• Autoimmune Diseases
• Cardiovascular Diseases
• Pain
• Neurology
• Other Applications

Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2019-2030 included in each section.
• Hospital Pharmacy
• Retail Pharmacy
• E-Commerce

Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ bn) are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Molecule Type, Drug Class, and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Amgen Inc.
Baxter International Inc.
Eli Lilly and Company
Gilead Sciences Inc.
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Moderna, Inc.
Novartis AG
Novo Nordisk AS
Pfizer Inc.
Sanofi SA
Teva Pharmaceuticals Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter’s Fiver Forces Analysis 39
3 Segmentation of Global Market by Molecule Type 43
3.1 Market Overview by Molecule Type 43
3.2 Small Molecule 45
3.3 Large Molecule 46
4 Segmentation of Global Market by Drug Class 47
4.1 Market Overview by Drug Class 47
4.2 Monoclonal Antibodies (mAbs) 49
4.3 Immunoglobulin 50
4.4 Insulin 51
4.5 Vaccines 52
4.6 Cytokines 53
4.7 Peptide Hormone 54
4.8 Blood Factors 55
4.9 Other Drug Classes 56
5 Segmentation of Global Market by Delivery 57
5.1 Market Overview by Delivery 57
5.2 Pre-filled Syringe 59
5.3 Infusions 60
5.4 Other Deliveries 61
6 Segmentation of Global Market by Application 62
6.1 Market Overview by Application 62
6.2 Oncology 64
6.3 Infectious Diseases 65
6.4 Autoimmune Diseases 66
6.5 Cardiovascular Diseases 67
6.6 Pain 68
6.7 Neurology 69
6.8 Other Applications 70
7 Segmentation of Global Market by Distribution Channel 71
7.1 Market Overview by Distribution Channel 71
7.2 Hospital Pharmacy 73
7.3 Retail Pharmacy 74
7.4 E-Commerce 75
8 Segmentation of Global Market by Region 76
8.1 Geographic Market Overview 2019-2030 76
8.2 North America Market 2019-2030 by Country 80
8.2.1 Overview of North America Market 80
8.2.2 U.S. 84
8.2.3 Canada 87
8.2.4 Mexico 89
8.3 European Market 2019-2030 by Country 91
8.3.1 Overview of European Market 91
8.3.2 Germany 95
8.3.3 U.K. 97
8.3.4 France 99
8.3.5 Spain 101
8.3.6 Italy 103
8.3.7 Russia 105
8.3.8 Rest of European Market 108
8.4 Asia-Pacific Market 2019-2030 by Country 110
8.4.1 Overview of Asia-Pacific Market 110
8.4.2 Japan 114
8.4.3 China 117
8.4.4 Australia 119
8.4.5 India 121
8.4.6 South Korea 123
8.4.7 Rest of APAC Region 125
8.5 South America Market 2019-2030 by Country 127
8.5.1 Argentina 130
8.5.2 Brazil 132
8.5.3 Chile 134
8.5.4 Rest of South America Market 136
8.6 MEA Market 2019-2030 by Country 137
8.6.1 UAE 140
8.6.2 Saudi Arabia 142
8.6.3 South Africa 144
8.6.4 Other National Markets 146
9 Competitive Landscape 147
9.1 Overview of Key Vendors 147
9.2 New Product Launch, Partnership, Investment, and M&A 150
9.3 Company Profiles 151
Amgen Inc. 151
Baxter International Inc. 153
Eli Lilly and Company 154
Gilead Sciences Inc. 155
GlaxoSmithKline PLC 156
Johnson & Johnson 157
Merck & Co. Inc. 158
Moderna, Inc. 159
Novartis AG 160
Novo Nordisk AS 161
Pfizer Inc. 162
Sanofi SA 163
Teva Pharmaceuticals Industries Ltd. 164
RELATED REPORTS 165

List of Tables:

Table 1. Snapshot of Global Injectable Drugs Market in Balanced Perspective, 2019-2030 19
Table 2. Growth Rate of World GDP, 2020-2022 23
Table 3. World Health Spending by Region, $ bn, 2013-2020 31
Table 4. Main Product Trends and Market Opportunities in Global Injectable Drugs Market 35
Table 5. Global Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 43
Table 6. Global Injectable Drugs Market by Drug Class, 2019-2030, $ bn 47
Table 7. Global Injectable Drugs Market by Delivery, 2019-2030, $ bn 57
Table 8. Global Injectable Drugs Market by Application, 2019-2030, $ bn 62
Table 9. Global Injectable Drugs Market by Distribution Channel, 2019-2030, $ bn 71
Table 10. Global Injectable Drugs Market by Region, 2019-2030, $ bn 77
Table 11. Leading National Injectable Drugs Market, 2019 and 2030F, $ bn 79
Table 12. North America Injectable Drugs Market by Country, 2019-2030, $ bn 82
Table 13. U.S. Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 86
Table 14. U.S. Injectable Drugs Market by Drug Class, 2019-2030, $ bn 86
Table 15. U.S. Injectable Drugs Market by Application, 2019-2030, $ bn 86
Table 16. Canada Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 88
Table 17. Canada Injectable Drugs Market by Drug Class, 2019-2030, $ bn 88
Table 18. Canada Injectable Drugs Market by Application, 2019-2030, $ bn 88
Table 19. Mexico Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 90
Table 20. Mexico Injectable Drugs Market by Drug Class, 2019-2030, $ bn 90
Table 21. Mexico Injectable Drugs Market by Application, 2019-2030, $ bn 90
Table 22. Europe Injectable Drugs Market by Country, 2019-2030, $ bn 94
Table 23. Germany Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 96
Table 24. Germany Injectable Drugs Market by Drug Class, 2019-2030, $ bn 96
Table 25. Germany Injectable Drugs Market by Application, 2019-2030, $ bn 96
Table 26. U.K. Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 98
Table 27. U.K. Injectable Drugs Market by Drug Class, 2019-2030, $ bn 98
Table 28. U.K. Injectable Drugs Market by Application, 2019-2030, $ bn 98
Table 29. France Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 100
Table 30. France Injectable Drugs Market by Drug Class, 2019-2030, $ bn 100
Table 31. France Injectable Drugs Market by Application, 2019-2030, $ bn 100
Table 32. Spain Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 102
Table 33. Spain Injectable Drugs Market by Drug Class, 2019-2030, $ bn 102
Table 34. Spain Injectable Drugs Market by Application, 2019-2030, $ bn 102
Table 35. Italy Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 104
Table 36. Italy Injectable Drugs Market by Drug Class, 2019-2030, $ bn 104
Table 37. Italy Injectable Drugs Market by Application, 2019-2030, $ bn 104
Table 38. Russia Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 106
Table 39. Russia Injectable Drugs Market by Drug Class, 2019-2030, $ bn 106
Table 40. Russia Injectable Drugs Market by Application, 2019-2030, $ bn 106
Table 41. Injectable Drugs Market in Rest of Europe by Country, 2019-2030, $ bn 109
Table 42. APAC Injectable Drugs Market by Country, 2019-2030, $ bn 112
Table 43. Japan Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 116
Table 44. Japan Injectable Drugs Market by Drug Class, 2019-2030, $ bn 116
Table 45. Japan Injectable Drugs Market by Application, 2019-2030, $ bn 116
Table 46. China Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 118
Table 47. China Injectable Drugs Market by Drug Class, 2019-2030, $ bn 118
Table 48. China Injectable Drugs Market by Application, 2019-2030, $ bn 118
Table 49. Australia Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 120
Table 50. Australia Injectable Drugs Market by Drug Class, 2019-2030, $ bn 120
Table 51. Australia Injectable Drugs Market by Application, 2019-2030, $ bn 120
Table 52. India Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 122
Table 53. India Injectable Drugs Market by Drug Class, 2019-2030, $ bn 122
Table 54. India Injectable Drugs Market by Application, 2019-2030, $ bn 122
Table 55. South Korea Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 124
Table 56. South Korea Injectable Drugs Market by Drug Class, 2019-2030, $ bn 124
Table 57. South Korea Injectable Drugs Market by Application, 2019-2030, $ bn 124
Table 58. Injectable Drugs Market in Rest of APAC by Country/Region, 2019-2030, $ bn 126
Table 59. South America Injectable Drugs Market by Country, 2019-2030, $ bn 129
Table 60. Argentina Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 131
Table 61. Argentina Injectable Drugs Market by Drug Class, 2019-2030, $ bn 131
Table 62. Argentina Injectable Drugs Market by Application, 2019-2030, $ bn 131
Table 63. Brazil Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 133
Table 64. Brazil Injectable Drugs Market by Drug Class, 2019-2030, $ bn 133
Table 65. Brazil Injectable Drugs Market by Application, 2019-2030, $ bn 133
Table 66. Chile Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 135
Table 67. Chile Injectable Drugs Market by Drug Class, 2019-2030, $ bn 135
Table 68. Chile Injectable Drugs Market by Application, 2019-2030, $ bn 135
Table 69. MEA Injectable Drugs Market by Country, 2019-2030, $ bn 139
Table 70. UAE Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 141
Table 71. UAE Injectable Drugs Market by Drug Class, 2019-2030, $ bn 141
Table 72. UAE Injectable Drugs Market by Application, 2019-2030, $ bn 141
Table 73. Saudi Arabia Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 143
Table 74. Saudi Arabia Injectable Drugs Market by Drug Class, 2019-2030, $ bn 143
Table 75. Saudi Arabia Injectable Drugs Market by Application, 2019-2030, $ bn 143
Table 76. South Africa Injectable Drugs Market by Molecule Type, 2019-2030, $ bn 145
Table 77. South Africa Injectable Drugs Market by Drug Class, 2019-2030, $ bn 145
Table 78. South Africa Injectable Drugs Market by Application, 2019-2030, $ bn 145
Table 79. Amgen Inc.: Company Snapshot 151
Table 80. Amgen Inc.: Business Segmentation 151
Table 81. Amgen Inc.: Product Portfolio 152
Table 82. Amgen Inc.: Revenue, 2018-2020, $ bn 152

 

 

List of Figures:

Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 18
Figure 4. Global Injectable Drugs Market, 2019-2030, $ bn 21
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of Global Injectable Drugs Market 27
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 9. Primary Restraints and Impact Factors of Global Injectable Drugs Market 32
Figure 10. Investment Opportunity Analysis 36
Figure 11. Porter’s Fiver Forces Analysis of Global Injectable Drugs Market 39
Figure 12. Breakdown of Global Injectable Drugs Market by Molecule Type, 2019-2030, % of Revenue 44
Figure 13. Global Addressable Market Cap in 2021-2030 by Molecule Type, Value ($ bn) and Share (%) 44
Figure 14. Global Injectable Drugs Market by Molecule Type: Small Molecule, 2019-2030, $ bn 45
Figure 15. Global Injectable Drugs Market by Molecule Type: Large Molecule, 2019-2030, $ bn 46
Figure 16. Breakdown of Global Injectable Drugs Market by Drug Class, 2019-2030, % of Sales Revenue 48
Figure 17. Global Addressable Market Cap in 2021-2030 by Drug Class, Value ($ bn) and Share (%) 48
Figure 18. Global Injectable Drugs Market by Drug Class: Monoclonal Antibodies (mAbs), 2019-2030, $ bn 49
Figure 19. Global Injectable Drugs Market by Drug Class: Immunoglobulin, 2019-2030, $ bn 50
Figure 20. Global Injectable Drugs Market by Drug Class: Insulin, 2019-2030, $ bn 51
Figure 21. Global Injectable Drugs Market by Drug Class: Vaccines, 2019-2030, $ bn 52
Figure 22. Global Injectable Drugs Market by Drug Class: Cytokines, 2019-2030, $ bn 53
Figure 23. Global Injectable Drugs Market by Drug Class: Peptide Hormone, 2019-2030, $ bn 54
Figure 24. Global Injectable Drugs Market by Drug Class: Blood Factors, 2019-2030, $ bn 55
Figure 25. Global Injectable Drugs Market by Drug Class: Other Drug Classes, 2019-2030, $ bn 56
Figure 26. Breakdown of Global Injectable Drugs Market by Delivery, 2019-2030, % of Sales Revenue 58
Figure 27. Global Addressable Market Cap in 2021-2030 by Delivery, Value ($ bn) and Share (%) 58
Figure 28. Global Injectable Drugs Market by Delivery: Pre-filled Syringe, 2019-2030, $ bn 59
Figure 29. Global Injectable Drugs Market by Delivery: Infusions, 2019-2030, $ bn 60
Figure 30. Global Injectable Drugs Market by Delivery: Other Deliveries, 2019-2030, $ bn 61
Figure 31. Breakdown of Global Injectable Drugs Market by Application, 2019-2030, % of Revenue 63
Figure 32. Global Addressable Market Cap in 2021-2030 by Application, Value ($ bn) and Share (%) 63
Figure 33. Global Injectable Drugs Market by Application: Oncology, 2019-2030, $ bn 64
Figure 34. Global Injectable Drugs Market by Application: Infectious Diseases, 2019-2030, $ bn 65
Figure 35. Global Injectable Drugs Market by Application: Autoimmune Diseases, 2019-2030, $ bn 66
Figure 36. Global Injectable Drugs Market by Application: Cardiovascular Diseases, 2019-2030, $ bn 67
Figure 37. Global Injectable Drugs Market by Application: Pain, 2019-2030, $ bn 68
Figure 38. Global Injectable Drugs Market by Application: Neurology, 2019-2030, $ bn 69
Figure 39. Global Injectable Drugs Market by Application: Other Applications, 2019-2030, $ bn 70
Figure 40. Breakdown of Global Injectable Drugs Market by Distribution Channel, 2019-2030, % of Revenue 72
Figure 41. Global Addressable Market Cap in 2021-2030 by Distribution Channel, Value ($ bn) and Share (%) 72
Figure 42. Global Injectable Drugs Market by Distribution Channel: Hospital Pharmacy, 2019-2030, $ bn 73
Figure 43. Global Injectable Drugs Market by Distribution Channel: Retail Pharmacy, 2019-2030, $ bn 74
Figure 44. Global Injectable Drugs Market by Distribution Channel: E-Commerce, 2019-2030, $ bn 75
Figure 45. Global Market Snapshot by Region 76
Figure 46. Geographic Spread of Worldwide Injectable Drugs Market, 2019-2030, % of Sales Revenue 77
Figure 47. Global Addressable Market Cap in 2021-2030 by Region, Value ($ bn) and Share (%) 78
Figure 48. North American Injectable Drugs Market, 2019-2030, $ bn 81
Figure 49. Breakdown of North America Injectable Drugs Market by Country, 2019 and 2030, % of Revenue 82
Figure 50. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%) 83
Figure 51. U.S. Injectable Drugs Market, 2019-2030, $ bn 85
Figure 52. Canada Injectable Drugs Market, 2019-2030, $ bn 87
Figure 53. Injectable Drugs Market in Mexico, 2019-2030, $ bn 89
Figure 54. European Injectable Drugs Market, 2019-2030, $ bn 92
Figure 55. Breakdown of European Injectable Drugs Market by Country, 2019 and 2030, % of Revenue 93
Figure 56. Contribution to Europe 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%) 94
Figure 57. Injectable Drugs Market in Germany, 2019-2030, $ bn 95
Figure 58. Injectable Drugs Market in U.K., 2019-2030, $ bn 97
Figure 59. Injectable Drugs Market in France, 2019-2030, $ bn 99
Figure 60. Injectable Drugs Market in Spain, 2019-2030, $ bn 101
Figure 61. Injectable Drugs Market in Italy, 2019-2030, $ bn 103
Figure 62. Injectable Drugs Market in Russia, 2019-2030, $ bn 105
Figure 63. Injectable Drugs Market in Rest of Europe, 2019-2030, $ bn 108
Figure 64. Asia-Pacific Injectable Drugs Market, 2019-2030, $ bn 111
Figure 65. Breakdown of APAC Injectable Drugs Market by Country, 2019 and 2030, % of Revenue 111
Figure 66. Contribution to APAC 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%) 113
Figure 67. Injectable Drugs Market in Japan, 2019-2030, $ bn 115
Figure 68. Injectable Drugs Market in China, 2019-2030, $ bn 117
Figure 69. Injectable Drugs Market in Australia, 2019-2030, $ bn 119
Figure 70. Injectable Drugs Market in India, 2019-2030, $ bn 121
Figure 71. Injectable Drugs Market in South Korea, 2019-2030, $ bn 123
Figure 72. Injectable Drugs Market in Rest of APAC, 2019-2030, $ bn 125
Figure 73. South America Injectable Drugs Market, 2019-2030, $ bn 128
Figure 74. Breakdown of South America Injectable Drugs Market by Country, 2019 and 2030, % of Revenue 128
Figure 75. Contribution to South America 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%) 129
Figure 76. Injectable Drugs Market in Argentina, 2019-2030, $ bn 130
Figure 77. Injectable Drugs Market in Brazil, 2019-2030, $ bn 132
Figure 78. Injectable Drugs Market in Chile, 2019-2030, $ bn 134
Figure 79. Injectable Drugs Market in Rest of South America, 2019-2030, $ bn 136
Figure 80. Injectable Drugs Market in Middle East and Africa (MEA), 2019-2030, $ bn 138
Figure 81. Breakdown of MEA Injectable Drugs Market by Country, 2019 and 2030, % of Revenue 138
Figure 82. Contribution to MEA 2021-2030 Cumulative Market by Country, Value ($ bn) and Share (%) 139
Figure 83. Injectable Drugs Market in UAE, 2019-2030, $ bn 140
Figure 84. Injectable Drugs Market in Saudi Arabia, 2019-2030, $ bn 142
Figure 85. Injectable Drugs Market in South Africa, 2019-2030, $ bn 144
Figure 86. Growth Stage of Global Injectable Drugs Industry over the Forecast Period 147

 

 

Reviews

There are yet no reviews for this product.